These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7581428)

  • 21. Stability of vaccines - bridging from stability data to continuous safety and efficacy throughout shelf life - an always reliable approach?
    Pfleiderer M
    Biologicals; 2009 Nov; 37(6):364-8. PubMed ID: 19773184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance levels for stability pooling test: a simulation study.
    Chen WJ; Tsong Y
    J Biopharm Stat; 2003 Aug; 13(3):355-74. PubMed ID: 12921387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of simultaneous variations in temperature and relative humidity on chemical stability of two vitamin C forms and implications for shelf life models.
    Hiatt AN; Taylor LS; Mauer LJ
    J Agric Food Chem; 2010 Mar; 58(6):3532-40. PubMed ID: 20163110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rank regression in stability analysis.
    Chen YQ; Pong A; Xing B
    J Biopharm Stat; 2003 Aug; 13(3):463-79. PubMed ID: 12921394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling the effects of storage temperature excursions on shelf life.
    Socarras S; Magari RT
    J Pharm Biomed Anal; 2009 Feb; 49(2):221-6. PubMed ID: 19058945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrixing Designs for Shelf-Life Determination of Parenteral Drug Product: A Comparative Analysis of Full and Reduced Stability Testing Design.
    Pavčnik L; Locatelli I; Trdan Lušin T; Roškar R
    Pharmaceutics; 2024 Aug; 16(9):. PubMed ID: 39339155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bayesian hierarchical modeling of drug stability data.
    Chen J; Zhong J; Nie L
    Stat Med; 2008 Jun; 27(13):2361-80. PubMed ID: 18338325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating Shelf Life Through Tolerance Intervals.
    Schwenke J; Quinlan M; Stroup W; Forenzo P
    AAPS PharmSciTech; 2020 Oct; 21(8):290. PubMed ID: 33079300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sample size estimation for GEE method for comparing slopes in repeated measurements data.
    Jung SH; Ahn C
    Stat Med; 2003 Apr; 22(8):1305-15. PubMed ID: 12687656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adaptive design and estimation in randomized clinical trials with correlated observations.
    Yin G; Shen Y
    Biometrics; 2005 Jun; 61(2):362-9. PubMed ID: 16011682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Practical Discussion on Estimating Shelf Life Through Tolerance Intervals.
    Schwenke J; Forenzo P; Stroup W; Quinlan M
    AAPS PharmSciTech; 2021 Nov; 22(8):273. PubMed ID: 34773146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A proposed "fixed" range decision criteria for transfer of bioanalytical methods.
    Shah KA; Karnes HT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(23):2270-4. PubMed ID: 19411196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined statistical analyses for long-term stability data with multiple storage conditions: a simulation study.
    Almalik O; Nijhuis MB; van den Heuvel ER
    J Biopharm Stat; 2014; 24(3):493-506. PubMed ID: 24697656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Forecast on shelf life of Chinese Angelica based on its chemical components variation].
    Xie JJ; Zhao J; Li SP
    Zhongguo Zhong Yao Za Zhi; 2008 Aug; 33(16):1997-2001. PubMed ID: 19086638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal adaptive design in clinical drug development: a simulation example.
    Maloney A; Karlsson MO; Simonsson US
    J Clin Pharmacol; 2007 Oct; 47(10):1231-43. PubMed ID: 17906158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adaptive designs in clinical drug development--an Executive Summary of the PhRMA Working Group.
    Gallo P; Chuang-Stein C; Dragalin V; Gaydos B; Krams M; Pinheiro J;
    J Biopharm Stat; 2006 May; 16(3):275-83; discussion 285-91, 293-8, 311-2. PubMed ID: 16724485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjusting dissolution specifications for the variability induced by storage conditions.
    Reynolds JM; Rogers DH
    J Biopharm Stat; 2000 Aug; 10(3):425-31. PubMed ID: 10959921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory requirements for veterinary vaccine stability in the European Community.
    Fawthrop D
    Dev Biol Stand; 1996; 87():319-27. PubMed ID: 8854032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pooling batches in drug stability study by using constant-width simultaneous confidence bands.
    Liu W; Jamshidian M; Zhang Y; Bretz F; Han XL
    Stat Med; 2007 Jun; 26(14):2759-71. PubMed ID: 17133619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of microbiological safety of ready-to-eat meat products by mathematical modelling: Listeria monocytogenes as an example.
    Carrasco E; Valero A; Pérez-Rodríguez F; García-Gimeno RM; Zurera G
    Int J Food Microbiol; 2007 Mar; 114(2):221-6. PubMed ID: 17140689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.